Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.
about
Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@ast
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@en
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@nl
type
label
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@ast
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@en
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@nl
prefLabel
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@ast
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@en
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@nl
P2093
P2860
P1433
P1476
Farnesyltransferase inhibitor, ...... e-induced acute liver failure.
@en
P2093
Fumito Ichinose
Kazuhiro Shirozu
Masao Kaneki
Shinsuke Hisaka
Shuichi Hirai
Tomokazu Tanaka
P2860
P304
P356
10.1097/SHK.0000000000000239
P577
2014-12-01T00:00:00Z